Literature DB >> 19900812

New potent 5-nitroindazole derivatives as inhibitors of Trypanosoma cruzi growth: synthesis, biological evaluation, and mechanism of action studies.

Jorge Rodríguez1, Vicente J Arán, Lucía Boiani, Claudio Olea-Azar, María Laura Lavaggi, Mercedes González, Hugo Cerecetto, Juan Diego Maya, Catalina Carrasco-Pozo, Hernán Speisky Cosoy.   

Abstract

New 5-nitroindazole derivatives were developed and their antichagasic properties studied. Eight compounds (14-18, 20, 26 and 28) displayed remarkable in vitro activities against Trypanosoma cruzi (T. cruzi). Its unspecific cytotoxicity against macrophages was evaluated being not toxic at a concentration at least twice that of T. cruzi IC(50), for some derivatives. The electrochemical studies, parasite respiration studies and ESR experiment showed that 5-nitroindazole derivatives not be able to yield a redox cycling with molecular oxygen such as occurs with nifurtimox (Nfx). The study on the mechanism of action proves to be related to the production of reduced species of the nitro moiety similar to that observed with benznidazole.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19900812     DOI: 10.1016/j.bmc.2009.10.030

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  8 in total

1.  Novel 3-nitro-1H-1,2,4-triazole-based piperazines and 2-amino-1,3-benzothiazoles as antichagasic agents.

Authors:  Maria V Papadopoulou; William D Bloomer; Howard S Rosenzweig; Marcel Kaiser; Eric Chatelain; Jean-Robert Ioset
Journal:  Bioorg Med Chem       Date:  2013-08-20       Impact factor: 3.641

2.  Novel 3-nitro-1H-1,2,4-triazole-based amides and sulfonamides as potential antitrypanosomal agents.

Authors:  Maria V Papadopoulou; William D Bloomer; Howard S Rosenzweig; Eric Chatelain; Marcel Kaiser; Shane R Wilkinson; Caroline McKenzie; Jean-Robert Ioset
Journal:  J Med Chem       Date:  2012-05-23       Impact factor: 7.446

Review 3.  Advances in Chagas disease drug development: 2009-2010.

Authors:  Frederick S Buckner; Nazlee Navabi
Journal:  Curr Opin Infect Dis       Date:  2010-12       Impact factor: 4.915

4.  Novel 3-nitro-1H-1,2,4-triazole-based aliphatic and aromatic amines as anti-chagasic agents.

Authors:  Maria V Papadopoulou; Bernadette Bourdin Trunz; William D Bloomer; Caroline McKenzie; Shane R Wilkinson; Chaiya Prasittichai; Reto Brun; Marcel Kaiser; Els Torreele
Journal:  J Med Chem       Date:  2011-11-04       Impact factor: 7.446

5.  Further insights into biological evaluation of new anti-Trypanosoma cruzi 5-nitroindazoles.

Authors:  Cristina Fonseca-Berzal; José Antonio Escario; Vicente J Arán; Alicia Gómez-Barrio
Journal:  Parasitol Res       Date:  2014-01-17       Impact factor: 2.289

6.  Dibenzylideneacetones Are Potent Trypanocidal Compounds That Affect the Trypanosoma cruzi Redox System.

Authors:  Danielle Lazarin-Bidóia; Vânia Cristina Desoti; Solange Cardoso Martins; Fabianne Martins Ribeiro; Zia Ud Din; Edson Rodrigues-Filho; Tânia Ueda-Nakamura; Celso Vataru Nakamura; Sueli de Oliveira Silva
Journal:  Antimicrob Agents Chemother       Date:  2015-11-23       Impact factor: 5.191

7.  Novel 3-nitro-1H-1,2,4-triazole-based compounds as potential anti-Chagasic drugs: in vivo studies.

Authors:  Maria V Papadopoulou; William D Bloomer; Howard S Rosenzweig; Rachel Ashworth; Shane R Wilkinson; Marcel Kaiser; Grasiella Andriani; Ana Rodriguez
Journal:  Future Med Chem       Date:  2013-10       Impact factor: 3.808

Review 8.  Synthetic Medicinal Chemistry in Chagas' Disease: Compounds at The Final Stage of "Hit-To-Lead" Phase.

Authors:  Hugo Cerecetto; Mercedes González
Journal:  Pharmaceuticals (Basel)       Date:  2010-03-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.